Europe Digital Polymerase Chain Reaction (PCR) Market - Industry Trends and Forecast to 2030

TABLE OF CONTENT

1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 54
1.3 OVERVIEW OF THE EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR) MARKET 54
1.4 LIMITATIONS 56
1.5 MARKETS COVERED 56
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 62
2.6 MULTIVARIATE MODELLING 65
2.7 PRODUCT TYPE LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 Cognate Lifesciences MARKET POSITION GRID 67
2.10 MARKET APPLICATION COVERAGE GRID 68
2.11 VENDOR SHARE ANALYSIS 69
2.12 SECONDARY SOURCES 70
2.13 ASSUMPTIONS 70
3 EXECUTIVE SUMMARY 71
4 PREMIUM INSIGHTS 73
4.1 PORTER’S FIVE FORCES 74
4.2 PESTEL ANALYSIS 75
4.3 MICRO AND MACRO ECONOMIC FACTORS 76
4.4 PENETRATION AND GROWTH PROSPECT MAPPING 76
4.5 KEY PRICING STRATEGIES 77
5 REGULATORY COMPLIANCE 78
5.1 REGULATORY AUTHORITIES 78
5.2 REGULATORY CLASSIFICATIONS 78
5.3 REGULATORY SUBMISSIONS 78
5.4 INTERNATIONAL HARMONIZATION 79
5.5 COMPLIANCE AND QUALITY MANAGEMENT SCENARIO 80
5.6 REGULATORY CHALLENGES AND STRATEGY 81
5.6.1 REGULATORY SCENARIO IN EUROPE 81
6 MARKET OVERVIEW 82
6.1 DRIVERS 84
6.1.1 RISE IN AVAILABILITY OF DIGITAL PCR DIAGNOSTICS 84
6.1.2 INCREASING APPLICATION OF DIGITAL PCR 84
6.1.3 INCREASING DEMAND FOR PERSONALIZED MEDICINE 85
6.2 RESTRAINTS 85
6.2.1 LIMITATIONS IN ANALYZING NOVEL COMPLEX DEVICES 85
6.2.2 HIGH COST OF DIGITAL PCR DEVICES 86
6.3 OPPORTUNITIES 86
6.3.1 RISING FREQUENCY OF INFECTIOUS DISEASES 86
6.3.2 RISING PRODUCT INNOVATIONS THROUGH R&D ACTIVITIES 86
6.4 CHALLENGES 87
6.4.1 STRINGENT REGULATIONS AND LEGAL CHALLENGES FOR DIGITAL PCR 87
6.4.2 LACK OF SKILLED PROFESSIONALS PERFORMING DIGITAL PCR 87
7 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY PRODUCT TYPE 89
7.1 OVERVIEW 90
7.2 DIGITAL PCR INSTRUMENTS 93
7.2.1 BY MODALITY 93
7.2.1.1 STANDLONE 93
7.2.1.2 PORTABLE 93
7.2.2 BY METHOD 93
7.2.2.1 PLATE-BASED DPCR 94
7.2.2.2 CHIP BASED DPCR 94
7.2.2.3 MICROFLUIDIC CHAMBER BASED DPCR 94
7.2.2.4 OTHERS 94
7.3 CONSUMABLES AND REAGENTS 94
7.3.1 REAGENTS 94
7.3.1.1 DNA OR PCR TEMPLATES 95
7.3.1.2 DNA POLYMERASE ENZYME 95
7.3.1.3 PRIMERS 95
7.3.1.4 DEXOYNUCLEOTIDE TRIPHOSPHATES (DNTPS) 95
7.3.1.5 PCR BUFFERS 95
7.3.1.6 PCR KIT 95 
7.3.2 CONSUMABLES 96
7.3.2.1 PLATES 96
7.3.2.2 TUBES & CAPS 96
7.3.2.3 PLASTIC ACCESSORIES 96
7.3.2.4 PLATE SEALS 96
7.3.2.5 CARTRIDGES 97
7.3.2.6 OTHERS 97
7.4 SOFTWARE AND SERVICES 97
8 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY TECHNOLOGY 98
8.1 OVERVIEW 99
8.2 DROPLET DIGITAL PCR 102
8.2.1 CLINICAL 102
8.2.2 LIFE SCIENCE & RESEARCH 102
8.2.3 OTHERS 102
8.3 BEAMING DIGITAL PCR 103
8.3.1 CLINICAL 103
8.3.2 LIFE SCIENCE & RESEARCH 103
8.3.3 OTHERS 103
9 EUROPE DIGITAL POLYMERASE CHAIN REACTION (PCR)MARKET, BY APPLICATION 104
9.1 OVERVIEW 105
9.2 CLINICAL 108
9.2.1 ONCOLOGY TESTING 108
9.2.2 INFECTIOUS DISEASE TESTING 108
9.2.2.1 HIV 109
9.2.2.2 HCV 109
9.2.2.3 HEPATITIS B VIRUS 109
9.2.2.4 HUMAN PAPILLOMAVIRUS 109
9.2.2.5 OTHERS 109
9.2.3 BLOOD SCREENING 109
9.2.4 TRANSPLANT DIAGNOSTICS 109
9.3 LIFE SCIENCE & RESEARCH 110
9.3.1 MICROBIOLOGY 110
9.3.2 MOLECULAR AND CELL BIOLOGY 110
9.3.3 OTHERS 110
9.4 OTHERS 110